Showing results (241-250 of 268) with videos related to

Sort By:
Pageof 27
Transplantation Proceedings|September 27, 2005
The treatment of fistulae and ureteral stenosis after kidney transplantationV Li Marzi, M T Filocamo, E Dattolo, et al.
The Journal of Infectious Diseases|December 8, 1998
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and IbC J Baker, L C Paoletti, M R Wessels, et al.
Cancer Research|December 1, 1987
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HClC Auclair, A Pierre, E Voisin, et al.
The Journal of Clinical Investigation|November 15, 1996
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccineD L Kasper, L C Paoletti, M R Wessels, et al.
Cancer|June 15, 1994
Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II studyB Neri, C Fiorelli, F Moroni, et al.
La Nouvelle Presse Medicale|April 21, 1979
[Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)]P Juret, A Tanguy, A Girard, et al.
Journal of Medicinal Chemistry|January 1, 1991
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedioneS Giorgi-Renault, J Renault, P Gebel-Servolles, et al.
The Journal of Infectious Diseases|September 9, 2000
Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy womenC J Baker, L C Paoletti, M A Rench, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 23, 2017
A graphene oxide pH sensor for wound monitoringB Melai, P Salvo, N Calisi, et al.
Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.
Pageof 27